Department of Orthopedics, Physical Medicine and Rehabilitation, University Hospital, LMU, Munich, Germany.
Department of Orthopedics and Trauma Surgery, Wertachklinik Bobingen, Bobingen, Germany.
Eur J Phys Rehabil Med. 2021 Oct;57(5):783-792. doi: 10.23736/S1973-9087.21.06553-9. Epub 2021 Jun 15.
In contrast to the broad evidence for the effectiveness of multidisciplinary biopsychosocial rehabilitation (MBR) in chronic low back pain (CLBP) patients of working age, little is known about the benefit in patients aged ≥65 years.
To quantify the short-term and 12-month effects of a 3-week CLBP specific MBR program in patients ≥65 years of age; to compare the effects in patients ≥65 years of age to the effects in younger patients.
Observational prospective cohort study.
Outpatient clinic at a tertiary physical medicine and rehabilitation center.
Consecutive patients with CLBP who participated in a CLBP specific MBR program.
The 3-week MBR program included 44 hours of treatment. The primary outcomes pain and disability were measured by the North American Spine Society Questionnaire (NASS). Secondary outcome measures were the Short-Form 36 (SF-36) and the numerical rating scale for pain. Effects were quantified using effect sizes (ES).
From 203 included patients, 104 patients older than 65 years (mean: 70.7; SD=4.0) were compared to 99 patients younger than 65 years (mean: 56.4; SD=6.7). The older patients had more comorbidities (two or more comorbidities: 49.5% versus 23.5%; P<0.001). Both groups showed significant improvements in pain and disability at discharge (both groups: P<0.001) and at the 12 months' follow-up (old: P<0.001; young: 0.039) with slightly higher effects for the older patients compared to the younger patients (discharge: ES=0.67 versus ES=0.53; 12 months: ES=0.42 versus ES=0.29). Both groups also improved in the SF-36 Physical Component Summary with slightly lower effects for the older patients (discharge: ES =0.31, P<0.001 versus ES=0.43, P<0.001; 12 months: ES=0.27, P=0.025 versus ES=0.39, P=0.001). The group differences of the change scores were not significant in any of the outcome measures.
MBR shows similar improvements in pain and disability in patients aged ≥ 65 compared to younger patients for at least 12 months.
The findings support the concept of MBR in the growing population of CLBP patients older than 65 years of age.
与多学科生物心理社会康复(MBR)在工作年龄慢性下腰痛(CLBP)患者中的广泛有效性证据形成对比的是,对于≥65 岁的患者,MBR 的益处知之甚少。
定量评估 3 周 CLBP 特定 MBR 方案对≥65 岁患者的短期和 12 个月疗效;比较≥65 岁患者与年轻患者的疗效。
观察性前瞻性队列研究。
三级物理医学和康复中心的门诊诊所。
参加 CLBP 特定 MBR 方案的连续 CLBP 患者。
3 周 MBR 方案包括 44 小时的治疗。主要结局疼痛和残疾通过北美脊柱协会问卷(NASS)进行测量。次要结局测量包括简短形式 36 项健康调查(SF-36)和疼痛数字评分量表。使用效应大小(ES)来量化疗效。
从 203 名纳入患者中,104 名年龄大于 65 岁的患者(平均:70.7;标准差=4.0)与 99 名年龄小于 65 岁的患者(平均:56.4;标准差=6.7)进行了比较。老年患者合并症更多(两种或更多种合并症:49.5%比 23.5%;P<0.001)。两组患者在出院时(两组:P<0.001)和 12 个月随访时(老年组:P<0.001;年轻组:0.039)疼痛和残疾均有显著改善,老年患者的疗效略高于年轻患者(出院时:ES=0.67 比 ES=0.53;12 个月时:ES=0.42 比 ES=0.29)。两组患者的 SF-36 躯体成分评分也有所改善,老年患者的疗效略低(出院时:ES=0.31,P<0.001 比 ES=0.43,P<0.001;12 个月时:ES=0.27,P=0.025 比 ES=0.39,P=0.001)。在任何结局测量中,组间变化评分的差异均无统计学意义。
MBR 在≥65 岁的患者中与年轻患者相比,至少在 12 个月内,疼痛和残疾的改善情况相似。
这些发现支持对≥65 岁的慢性下腰痛患者进行 MBR 的概念。